English
简体中文
Total: £ 56.28
Published Date: 2024-12-06 | Pages: 110 | Tables: 183 | Medical Care
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global market for Infectious Disease In Vitro Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In Vitro Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Disease In Vitro Diagnostics by region & country, by Type, and by Application.
The Infectious Disease In Vitro Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In Vitro Diagnostics.
Market Segmentation
By Company
QIAGEN
BD
bioMérieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Segment by Type:
Instruments
Reagents
Segment by Application
Hospitals & Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Disease In Vitro Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Disease In Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Disease In Vitro Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Infectious Disease In Vitro Diagnostics Product Introduction
1.2 Global Infectious Disease In Vitro Diagnostics Market Size Forecast
1.3 Infectious Disease In Vitro Diagnostics Market Trends & Drivers
1.3.1 Infectious Disease In Vitro Diagnostics Industry Trends
1.3.2 Infectious Disease In Vitro Diagnostics Market Drivers & Opportunity
1.3.3 Infectious Disease In Vitro Diagnostics Market Challenges
1.3.4 Infectious Disease In Vitro Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Infectious Disease In Vitro Diagnostics Players Revenue Ranking (2023)
2.2 Global Infectious Disease In Vitro Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Infectious Disease In Vitro Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infectious Disease In Vitro Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Infectious Disease In Vitro Diagnostics
2.6 Infectious Disease In Vitro Diagnostics Market Competitive Analysis
2.6.1 Infectious Disease In Vitro Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Infectious Disease In Vitro Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Instruments
3.1.2 Reagents
3.2 Global Infectious Disease In Vitro Diagnostics Sales Value by Type
3.2.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Infectious Disease In Vitro Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Infectious Disease In Vitro Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals & Clinics
4.1.2 Diagnostic Laboratories
4.1.3 Others
4.2 Global Infectious Disease In Vitro Diagnostics Sales Value by Application
4.2.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Infectious Disease In Vitro Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Infectious Disease In Vitro Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Region
5.1.1 Global Infectious Disease In Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Infectious Disease In Vitro Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
5.2.2 North America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
5.3.2 Europe Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
5.5.2 South America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value
6.3 United States
6.3.1 United States Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.3.2 United States Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.4.2 Europe Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.5.2 China Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.6.2 Japan Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Infectious Disease In Vitro Diagnostics Sales Value, 2019-2030
6.9.2 India Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Infectious Disease In Vitro Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 QIAGEN
7.1.1 QIAGEN Profile
7.1.2 QIAGEN Main Business
7.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.1.4 QIAGEN Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 QIAGEN Recent Developments
7.2 BD
7.2.1 BD Profile
7.2.2 BD Main Business
7.2.3 BD Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.2.4 BD Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 BD Recent Developments
7.3 bioMérieux SA
7.3.1 bioMérieux SA Profile
7.3.2 bioMérieux SA Main Business
7.3.3 bioMérieux SA Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.3.4 bioMérieux SA Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 F. Hoffmann-La Roche, Ltd. Recent Developments
7.4 F. Hoffmann-La Roche, Ltd.
7.4.1 F. Hoffmann-La Roche, Ltd. Profile
7.4.2 F. Hoffmann-La Roche, Ltd. Main Business
7.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.4.4 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 F. Hoffmann-La Roche, Ltd. Recent Developments
7.5 Hologic, Inc. (Gen-Probe)
7.5.1 Hologic, Inc. (Gen-Probe) Profile
7.5.2 Hologic, Inc. (Gen-Probe) Main Business
7.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.5.4 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Hologic, Inc. (Gen-Probe) Recent Developments
7.6 Abbott
7.6.1 Abbott Profile
7.6.2 Abbott Main Business
7.6.3 Abbott Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.6.4 Abbott Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Recent Developments
7.7 Quidel Corp.
7.7.1 Quidel Corp. Profile
7.7.2 Quidel Corp. Main Business
7.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.7.4 Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Quidel Corp. Recent Developments
7.8 Siemens Healthineers AG
7.8.1 Siemens Healthineers AG Profile
7.8.2 Siemens Healthineers AG Main Business
7.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.8.4 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Siemens Healthineers AG Recent Developments
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Profile
7.9.2 Bio-Rad Laboratories, Inc. Main Business
7.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.9.4 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Bio-Rad Laboratories, Inc. Recent Developments
7.10 Danaher Corp.
7.10.1 Danaher Corp. Profile
7.10.2 Danaher Corp. Main Business
7.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.10.4 Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Danaher Corp. Recent Developments
7.11 OraSure Technologies, Inc.
7.11.1 OraSure Technologies, Inc. Profile
7.11.2 OraSure Technologies, Inc. Main Business
7.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
7.11.4 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 OraSure Technologies, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Infectious Disease In Vitro Diagnostics Industrial Chain
8.2 Infectious Disease In Vitro Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Infectious Disease In Vitro Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Infectious Disease In Vitro Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Infectious Disease In Vitro Diagnostics Market Trends
Table 2. Infectious Disease In Vitro Diagnostics Market Drivers & Opportunity
Table 3. Infectious Disease In Vitro Diagnostics Market Challenges
Table 4. Infectious Disease In Vitro Diagnostics Market Restraints
Table 5. Global Infectious Disease In Vitro Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Infectious Disease In Vitro Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Infectious Disease In Vitro Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Infectious Disease In Vitro Diagnostics
Table 10. Global Infectious Disease In Vitro Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In Vitro Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Infectious Disease In Vitro Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Infectious Disease In Vitro Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Infectious Disease In Vitro Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Infectious Disease In Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Infectious Disease In Vitro Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. QIAGEN Basic Information List
Table 32. QIAGEN Description and Business Overview
Table 33. QIAGEN Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of QIAGEN (2019-2024)
Table 35. QIAGEN Recent Developments
Table 36. BD Basic Information List
Table 37. BD Description and Business Overview
Table 38. BD Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of BD (2019-2024)
Table 40. BD Recent Developments
Table 41. bioMérieux SA Basic Information List
Table 42. bioMérieux SA Description and Business Overview
Table 43. bioMérieux SA Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of bioMérieux SA (2019-2024)
Table 45. bioMérieux SA Recent Developments
Table 46. F. Hoffmann-La Roche, Ltd. Basic Information List
Table 47. F. Hoffmann-La Roche, Ltd. Description and Business Overview
Table 48. F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of F. Hoffmann-La Roche, Ltd. (2019-2024)
Table 50. F. Hoffmann-La Roche, Ltd. Recent Developments
Table 51. Hologic, Inc. (Gen-Probe) Basic Information List
Table 52. Hologic, Inc. (Gen-Probe) Description and Business Overview
Table 53. Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Hologic, Inc. (Gen-Probe) (2019-2024)
Table 55. Hologic, Inc. (Gen-Probe) Recent Developments
Table 56. Abbott Basic Information List
Table 57. Abbott Description and Business Overview
Table 58. Abbott Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Abbott (2019-2024)
Table 60. Abbott Recent Developments
Table 61. Quidel Corp. Basic Information List
Table 62. Quidel Corp. Description and Business Overview
Table 63. Quidel Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Quidel Corp. (2019-2024)
Table 65. Quidel Corp. Recent Developments
Table 66. Siemens Healthineers AG Basic Information List
Table 67. Siemens Healthineers AG Description and Business Overview
Table 68. Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Siemens Healthineers AG (2019-2024)
Table 70. Siemens Healthineers AG Recent Developments
Table 71. Bio-Rad Laboratories, Inc. Basic Information List
Table 72. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 73. Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Bio-Rad Laboratories, Inc. (2019-2024)
Table 75. Bio-Rad Laboratories, Inc. Recent Developments
Table 76. Danaher Corp. Basic Information List
Table 77. Danaher Corp. Description and Business Overview
Table 78. Danaher Corp. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of Danaher Corp. (2019-2024)
Table 80. Danaher Corp. Recent Developments
Table 81. OraSure Technologies, Inc. Basic Information List
Table 82. OraSure Technologies, Inc. Description and Business Overview
Table 83. OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Infectious Disease In Vitro Diagnostics Business of OraSure Technologies, Inc. (2019-2024)
Table 85. OraSure Technologies, Inc. Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Infectious Disease In Vitro Diagnostics Downstream Customers
Table 89. Infectious Disease In Vitro Diagnostics Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Infectious Disease In Vitro Diagnostics Product Picture
Figure 2. Global Infectious Disease In Vitro Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Infectious Disease In Vitro Diagnostics Report Years Considered
Figure 5. Global Infectious Disease In Vitro Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Disease In Vitro Diagnostics Revenue in 2023
Figure 7. Infectious Disease In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Instruments Picture
Figure 9. Reagents Picture
Figure 10. Global Infectious Disease In Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Infectious Disease In Vitro Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals & Clinics
Figure 13. Product Picture of Diagnostic Laboratories
Figure 14. Product Picture of Others
Figure 15. Global Infectious Disease In Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Infectious Disease In Vitro Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Infectious Disease In Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Infectious Disease In Vitro Diagnostics Sales Value (%), (2019-2030)
Figure 28. United States Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 34. China Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 36. China Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 46. India Infectious Disease In Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Infectious Disease In Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 48. India Infectious Disease In Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 49. Infectious Disease In Vitro Diagnostics Industrial Chain
Figure 50. Infectious Disease In Vitro Diagnostics Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
